Our researchers are currently in need of adult and pediatric study participants to help us pursue better treatments and cures. Participants may receive medical evaluations and procedures, study medication, disease-related education and possible financial compensation for time, travel and participation.
Select a Condition
Age
Compensation
Do you have systemic sclerosis-associated pulmonary arterial hypertension (PAH)? Our researchers are trying to determine if a new medication, Tecfidera®, helps improve quality of life for patients with this disease.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study.
People with systemic lupus erythematosus (SLE) may be able to improve brain function with Project EVO, an interactive digital technology currently in development with Akili Interactive. Learn more.
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Does your mind race at night when you're trying to sleep? Our researchers are studying how people with insomnia and obstructive sleep apnea can benefit from cognitive behavioral therapy, a goal-oriented type of treatment that aims to identify and change inaccurate or negative thinking patterns...
Does your child have mild-to-severe eczema? They may qualify for a clinical trial to see if an investigational medication can safely and effectively reduce their symptoms. Compensation is provided.
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
The purpose of this study is to determine how two medications, azithromycin and inhaled tobramycin, work when taken together to treat cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) lung infections.
Our researchers are studying how to help people use positive airway pressure (PAP) to treat their obstructive sleep apnea, a serious disorder that, if left untreated, can lead to high blood pressure, stroke, heart problems, diabetes and depression.
Are you one of the many people with atopic dermatitis (eczema) who continues to have dry, itchy skin, and repeat infections that are not controlled by your medicine? Our researchers are seeking participants for a clinical trial that will test a medication called dupilumab that was recently...
Our researchers are studying an investigational combination of medications, one used to treat asthma in adults and the other not yet approved to treat adult asthma, to determine if it can improve symptoms and lung function in asthma patients age 5 to 17.
Chronic obstructive pulmonary disease (COPD) patients age 40-85 are needed for a clinical trial to see if a commonly prescribed heart medication can reduce COPD flare-ups.
Our researchers are studying an investigational medication to determine if it improves lung function in teens with asthma. By blocking a key receptor that causes inflammation in the lungs, the medication may improve and prevent symptoms such as wheezing and shortness of breath.
Is your asthma poorly controlled despite using inhalers? Our researchers are studying an investigational medicine that targets a substance known to play a role in causing asthma. You may be able to help them determine if this medication is effective in treating severe asthma.
Our researchers are studying glycerol phenylbutyrate (GPBA), also known as RAVICTI®, to determine how safe it is and how well people tolerate it in the treatment of cystic fibrosis (CF).
The purpose of this study is to test the effectiveness of a new investigational medication, PTI-801, in treating cystic fibrosis (CF).
The purpose of this study is to learn more about how Opsumit® (the commercial form of the medication macitentan) is used in clinical practice to treat pulmonary arterial hypertension (PAH) and other conditions.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 year
Adults age 40 or older are needed to help our researchers determine if an investigational medication can help slow damage to the lungs in people who have COPD with emphysema.
Do you have alpha-1 with emphysema? Our researchers want to learn if an investigational medication, a hyaluronic acid inhalation solution, can be used to treat adults who have alpha-1 antitrypsin deficiency (AATD) with emphysema.
-
Gender: Any Gender
-
Ages: 18-80
-
Compensation: Provided
-
Time Required: 5 visits
/Image_3097-small.jpg.aspx?width=428&height=244&ext=.jpg)
The purpose of this study is to see if a drug called sirolimus slows development of lymphangioleiomyomatosis (LAM), a lung disease in which abnormal cells growing inside the lungs prevent them from working properly.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 2 years
The purpose of this study is to gather information about treatment of early-stage lung cancer in order to compare the effectiveness of surgery versus radiation therapy, potentially improving outcomes for patients with early-stage lung cancer.
The purpose of this clinical trial is to see if it better to receive an investigational medication or no further treatment after surgery (and possibly chemotherapy) to remove non-small cell lung cancer (NSCLC).
The purpose of this clinical trial is to study the safety and potential benefits of treating fibrotic hypersensitivity pneumonitis (FHP) with an investigational medication.
Do you have pulmonary hypertension (PH) related to lung disease? You may qualify for a clinical trial to help researchers determine the safety and effectiveness of an investigational medication.
If you are age 18 to 65 with asthma not improved by inhaled steroids, you may be eligible to participate in a clinical trial and try a new investigational medication.
What are the positive and negative long-term medical effects of marijuana use? You can help our researchers find out if you live in Colorado, are age 21 to 80 and use marijuana regularly.
Our researchers are looking for people with and without sarcoidosis for a clinical trial on genetic markers associated with the disease.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 visit
How does inflammation differ in psoriasis and atopic dermatitis (eczema) patients? Our researchers are trying to find out. If you or your child (age 12 or older) has a history of psoriasis, we need your help for a clinical trial.
-Study/Ezcema-Study.jpg.aspx?width=428&height=244&ext=.jpg)
If you or your child age 3 or older has atopic dermatitis (eczema), you may be able to help our researchers learn why some people with eczema have increased risk of skin infection.
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
Are you 18 or older with no history of chronic lung conditions? You may be able to help our researchers better understand lung disease. Compensation provided.
Do you have rheumatoid arthritis and interstitial lung disease (RA-ILD)? You may be able to help our researchers determine if people with RA-ILD can benefit from a medication called Pirfenidone, which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic...
The purpose of this research study is to determine if an investigational medication can reduce inflammation, tissue scarring, and the number of pulmonary exacerbations, or episodes when breathing is more difficult, in people with cystic fibrosis (CF).
Our researchers are looking at whether high-dose vitamin D supplementation can prevent severe asthma exacerbations.
Are you pregnant? Do you have a family history of allergic disease (asthma, eczema, environmental allergies, hay fever, etc.)? You may be able to help our researchers determine if your child and others are at risk of developing eczema and food allergies.
-
Gender: Any Gender
-
Ages: Parents 18-50, newborns 3-6 months
-
Compensation: Not Provided
-
Time Required: Four 1-hour visits over 6 months
.jpg.aspx?width=428&height=244&ext=.jpg)
Do you have eczema? If you are age 18 to 60, you may qualify for an NIH sponsored clinical trial to see if an investigational lotion is safe and if the lotion reduces or even eliminates, bacteria that cause skin infections. Compensation provided for qualified participants.
Do you have systemic sclerosis-associated pulmonary arterial hypertension (PAH)? Our researchers are trying to determine if a new medication, Tecfidera®, helps improve quality of life for patients with this disease.
The purpose of this study is to measure and accurately identify the presence and severity of gastroesphageal reflux disease (GERD), commonly called acid reflux, in idiopathic pulmonary fibrosis (IPF) patients using the Supraglottic Index (SGI).
Our researchers are studying the lungs of current and former smokers to understand how to improve the diagnosis and treatment of Chronic Obstructive Pulmonary Disease (COPD), a disease that is common among smokers. You do not need to have COPD to participate in this study.
People with systemic lupus erythematosus (SLE) may be able to improve brain function with Project EVO, an interactive digital technology currently in development with Akili Interactive. Learn more.
If you are an adult with sarcoidosis who is not on immunosuppressive therapy, you may be able to help our researchers learn more about different types of sarcoidosis and how it develops.
Does your mind race at night when you're trying to sleep? Our researchers are studying how people with insomnia and obstructive sleep apnea can benefit from cognitive behavioral therapy, a goal-oriented type of treatment that aims to identify and change inaccurate or negative thinking patterns...
Our researchers are studying lung diseases that develop from inhaling mineral dust over time. Although the cause of diseases such as "black lung" are known, it is not well understood why some people develop these diseases and others don't.
The purpose of this study is to determine how two medications, azithromycin and inhaled tobramycin, work when taken together to treat cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) lung infections.
Our researchers are studying how to help people use positive airway pressure (PAP) to treat their obstructive sleep apnea, a serious disorder that, if left untreated, can lead to high blood pressure, stroke, heart problems, diabetes and depression.
Are you one of the many people with atopic dermatitis (eczema) who continues to have dry, itchy skin, and repeat infections that are not controlled by your medicine? Our researchers are seeking participants for a clinical trial that will test a medication called dupilumab that was recently...
Chronic obstructive pulmonary disease (COPD) patients age 40-85 are needed for a clinical trial to see if a commonly prescribed heart medication can reduce COPD flare-ups.
Is your asthma poorly controlled despite using inhalers? Our researchers are studying an investigational medicine that targets a substance known to play a role in causing asthma. You may be able to help them determine if this medication is effective in treating severe asthma.
Our researchers are studying glycerol phenylbutyrate (GPBA), also known as RAVICTI®, to determine how safe it is and how well people tolerate it in the treatment of cystic fibrosis (CF).
The purpose of this study is to test the effectiveness of a new investigational medication, PTI-801, in treating cystic fibrosis (CF).
The purpose of this study is to learn more about how Opsumit® (the commercial form of the medication macitentan) is used in clinical practice to treat pulmonary arterial hypertension (PAH) and other conditions.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 year
Adults age 40 or older are needed to help our researchers determine if an investigational medication can help slow damage to the lungs in people who have COPD with emphysema.
Do you have alpha-1 with emphysema? Our researchers want to learn if an investigational medication, a hyaluronic acid inhalation solution, can be used to treat adults who have alpha-1 antitrypsin deficiency (AATD) with emphysema.
-
Gender: Any Gender
-
Ages: 18-80
-
Compensation: Provided
-
Time Required: 5 visits
The purpose of this study is to see if a drug called sirolimus slows development of lymphangioleiomyomatosis (LAM), a lung disease in which abnormal cells growing inside the lungs prevent them from working properly.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 2 years
The purpose of this study is to gather information about treatment of early-stage lung cancer in order to compare the effectiveness of surgery versus radiation therapy, potentially improving outcomes for patients with early-stage lung cancer.
The purpose of this clinical trial is to see if it better to receive an investigational medication or no further treatment after surgery (and possibly chemotherapy) to remove non-small cell lung cancer (NSCLC).
The purpose of this clinical trial is to study the safety and potential benefits of treating fibrotic hypersensitivity pneumonitis (FHP) with an investigational medication.
Do you have pulmonary hypertension (PH) related to lung disease? You may qualify for a clinical trial to help researchers determine the safety and effectiveness of an investigational medication.
If you are age 18 to 65 with asthma not improved by inhaled steroids, you may be eligible to participate in a clinical trial and try a new investigational medication.
What are the positive and negative long-term medical effects of marijuana use? You can help our researchers find out if you live in Colorado, are age 21 to 80 and use marijuana regularly.
Our researchers are looking for people with and without sarcoidosis for a clinical trial on genetic markers associated with the disease.
-
Gender: Any Gender
-
Ages: 18+
-
Compensation: Provided
-
Time Required: 1 visit
How does inflammation differ in psoriasis and atopic dermatitis (eczema) patients? Our researchers are trying to find out. If you or your child (age 12 or older) has a history of psoriasis, we need your help for a clinical trial.
If you or your child age 3 or older has atopic dermatitis (eczema), you may be able to help our researchers learn why some people with eczema have increased risk of skin infection.
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.
Are you 18 or older with no history of chronic lung conditions? You may be able to help our researchers better understand lung disease. Compensation provided.
Do you have rheumatoid arthritis and interstitial lung disease (RA-ILD)? You may be able to help our researchers determine if people with RA-ILD can benefit from a medication called Pirfenidone, which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic...
The purpose of this research study is to determine if an investigational medication can reduce inflammation, tissue scarring, and the number of pulmonary exacerbations, or episodes when breathing is more difficult, in people with cystic fibrosis (CF).
Do you have eczema? If you are age 18 to 60, you may qualify for an NIH sponsored clinical trial to see if an investigational lotion is safe and if the lotion reduces or even eliminates, bacteria that cause skin infections. Compensation provided for qualified participants.
Does your child have mild-to-severe eczema? They may qualify for a clinical trial to see if an investigational medication can safely and effectively reduce their symptoms. Compensation is provided.
The purpose of this study is to determine how two medications, azithromycin and inhaled tobramycin, work when taken together to treat cystic fibrosis (CF) patients with chronic pseudomonas aeruginosa (PA) lung infections.
Our researchers are studying an investigational combination of medications, one used to treat asthma in adults and the other not yet approved to treat adult asthma, to determine if it can improve symptoms and lung function in asthma patients age 5 to 17.
Our researchers are studying an investigational medication to determine if it improves lung function in teens with asthma. By blocking a key receptor that causes inflammation in the lungs, the medication may improve and prevent symptoms such as wheezing and shortness of breath.
How does inflammation differ in psoriasis and atopic dermatitis (eczema) patients? Our researchers are trying to find out. If you or your child (age 12 or older) has a history of psoriasis, we need your help for a clinical trial.
If you or your child age 3 or older has atopic dermatitis (eczema), you may be able to help our researchers learn why some people with eczema have increased risk of skin infection.
The purpose of this research study is to determine if an investigational medication can reduce inflammation, tissue scarring, and the number of pulmonary exacerbations, or episodes when breathing is more difficult, in people with cystic fibrosis (CF).
Our researchers are looking at whether high-dose vitamin D supplementation can prevent severe asthma exacerbations.
Are you pregnant? Do you have a family history of allergic disease (asthma, eczema, environmental allergies, hay fever, etc.)? You may be able to help our researchers determine if your child and others are at risk of developing eczema and food allergies.
-
Gender: Any Gender
-
Ages: Parents 18-50, newborns 3-6 months
-
Compensation: Not Provided
-
Time Required: Four 1-hour visits over 6 months